436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study.
Saved in:
| Title: | 436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study. |
|---|---|
| Authors: | Brahm, C.G.1 (AUTHOR), van Linde, M.E.1 (AUTHOR), Labots, M.1 (AUTHOR), Kouwenhoven, M.C.M.2 (AUTHOR), Sanchez Aliaga, E.3 (AUTHOR), Enting, R.H.4 (AUTHOR), Appelman, A.P.A.5 (AUTHOR), Nuver, J.6 (AUTHOR), Walenkamp, A.M.E.6 (AUTHOR), Verheul, H.M.W.7 (AUTHOR) |
| Source: | Annals of Oncology. 2019 Supplement 6, Vol. 30, pv157-v158. 2p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 152683078 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Brahm%2C+C%2EG%2E%22">Brahm, C.G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Linde%2C+M%2EE%2E%22">van Linde, M.E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Labots%2C+M%2E%22">Labots, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kouwenhoven%2C+M%2EC%2EM%2E%22">Kouwenhoven, M.C.M.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sanchez+Aliaga%2C+E%2E%22">Sanchez Aliaga, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Enting%2C+R%2EH%2E%22">Enting, R.H.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Appelman%2C+A%2EP%2EA%2E%22">Appelman, A.P.A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nuver%2C+J%2E%22">Nuver, J.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Walenkamp%2C+A%2EM%2EE%2E%22">Walenkamp, A.M.E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verheul%2C+H%2EM%2EW%2E%22">Verheul, H.M.W.</searchLink><relatesTo>7</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2019 Supplement 6, Vol. 30, pv157-v158. 2p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=152683078 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdz243.046 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 2 StartPage: v157 Titles: – TitleFull: 436TiP - A phase II/III trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma: The STELLAR study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brahm, C.G. – PersonEntity: Name: NameFull: van Linde, M.E. – PersonEntity: Name: NameFull: Labots, M. – PersonEntity: Name: NameFull: Kouwenhoven, M.C.M. – PersonEntity: Name: NameFull: Sanchez Aliaga, E. – PersonEntity: Name: NameFull: Enting, R.H. – PersonEntity: Name: NameFull: Appelman, A.P.A. – PersonEntity: Name: NameFull: Nuver, J. – PersonEntity: Name: NameFull: Walenkamp, A.M.E. – PersonEntity: Name: NameFull: Verheul, H.M.W. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 10 Text: 2019 Supplement 6 Type: published Y: 2019 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 30 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |